a public good project by the
Synthesis
Company
of California

© 2026

Chuck Kriemen | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

Chuck Kriemen

Amgen (United States)(US)

Research Areas

Alzheimer's disease research and treatments, Drug Transport and Resistance Mechanisms, Macrophage Migration Inhibitory Factor

Most-Cited Works

→ A Potent and Orally Efficacious, Hydroxyethylamine-Based Inhibitor of β-Secretase(2012)28 cited